Mehra, et al. created a doxorubicin-induced rat model of cardiotoxicity to mimic human dilated cardiomyopathy and observed significant increases in CTSL activity and protein expression levels in rats treated with doxorubicin compared with the control group [17]. The gene discussed is CTSL; the disease is dilated cardiomyopathy.